NCT05875766 (DIDT OSTEO) is a NA clinical trial of Osteopathy in Cruciate Ligament Rupture, sponsored by Ramsay Générale de Santé.

Who is sponsoring NCT05875766?

NCT05875766 is sponsored by Ramsay Générale de Santé.

What drugs are being tested in NCT05875766?

Interventions in NCT05875766: Osteopathy, Physiotherapy.

What condition does NCT05875766 study?

NCT05875766 studies Cruciate Ligament Rupture, Knee Ligament Injury, Osteopathia.

Is NCT05875766 still recruiting?

NCT05875766 is currently status unknown. Last updated 25 May 2023.

Last reviewed 2023-05-25 · How we verify

NCT05875766: DIDT OSTEO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Osteopathic Care After Rupture of the Antero-external Cruciate Ligament of the Knee (DIDT OSTEO)

Status unknown NA Last updated 25 May 2023

What this trial tests

NA trial testing Osteopathy in Cruciate Ligament Rupture in 94 participants. Status unknown.

Timeline

7 April 2023

Primary endpoint
7 April 2024

7 December 2024

Quick facts

Lead sponsor	Ramsay Générale de Santé
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	94
Start date	7 April 2023
Primary completion	7 April 2024
Estimated completion	7 December 2024
Sites	1 location across France

Drugs / interventions tested

Osteopathy
Physiotherapy — full drug profile →

Conditions studied

Cruciate Ligament Rupture — all drugs for Cruciate Ligament Rupture →
Knee Ligament Injury — all drugs for Knee Ligament Injury →
Osteopathia — all drugs for Osteopathia →

Sponsor

Ramsay Générale de Santé — full company profile →

Who can join

Adults 18 to 35, any sex, with Cruciate Ligament Rupture or Knee Ligament Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The antero-external cruciate ligament (ACL) is the ligament located inside the knee, which allows the rotation of the knee by stabilizing the femur and the tibia. Rupture of the ACL is common during the practice of certain so-called "pivot" sports, whether contact or not. It is manifested by acute pain or instability of the knee, following a crack during a twist and/or a blockage of the joint. The diagnosis will be confirmed by a clinical examination and X-rays to eliminate any fracture or tearing and by MRI to visualize the ligament rupture and the associated lesions, in particular a lesion of the meniscus. Treatment is required because the ruptured ligament does not heal on its own and the rupture of the ligament may eventually promote the appearance of osteoarthritis. Two types of treatment can be considered, rehabilitation or surgery, depending on the patient's age and motivation to resume sports. There are several surgical techniques, the most common is to reconstruct the ruptured ligament by arthroscopy using a graft taken from the tendons of the Internal Rectus and Demi muscles tendinous (DIDT). Rehabilitation by physiotherapy is often started preoperatively and immediately after the operation, as soon as you wake up, to find a functional and painless knee. Functional recovery often depends on patient motivation. The main objective is to show that osteopathic care in addition to physiotherapy rehabilitation improves knee functionality in patients 6 months after reconstruction of the ACL by DIDT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Osteopathy

Trials testing the same drug.

NCT06649903 — Cervical Spinal Manipulation and Visteral Osteopathy for Mechanical Neck Pain · NA · completed
NCT04159311 — Osteopathy on IBS Symptoms in Patients With Ulcerative Colitis in Remission · NA · terminated
NCT02584049 — Osteopathic Medicine in the Management of Care-induced Pain in Elderly Care (OGéDIS) · NA · terminated

Other recruiting trials for Cruciate Ligament Rupture

Currently open trials in the same condition.

NCT04184687 — The Treatment of Cartilaginous Lesions and Concomitant Anterior Cruciate Ligament Reconstruction · NA · recruiting

Other Ramsay Générale de Santé trials

Trials by the same sponsor.

NCT07353060 — Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT) · NA · not yet recruiting
NCT07245823 — Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineo · NA · recruiting
NCT07142330 — Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries · not yet recruiting
NCT07203131 — Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Ca · NA · recruiting
NCT07469007 — Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05875766 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ramsay Générale de Santé
Last refreshed: 25 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05875766.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing